Drugs & medicalClass II

Tailstorm Health INC recalls BEVACIZUMAB (AVASTIN)1.25mg/0.05mL, Sterile Injection, 0.5 mL Single-Dose Syringe, Rx Only, Repackaged by: Medivant Healthcare: 24416 N…

Lack of Sterility Assurance

Read the official notice →
Date
2024-11-27
Country
United States
Brand
Tailstorm Health
Product
BEVACIZUMAB (AVASTIN)1.25mg/0.05mL, Sterile Injection, 0.5 mL Single-Dose Syringe, Rx Only, Repackaged by: Medivant Healthcare: 24416 N…
Classification
Class II
Units
Nationwide Within U.S.
Category
Drugs & medical
Source
FDA · Drug

Copied automatically from the US Food and Drug Administration. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer

What to do

  1. Check the product name, strength and lot number against the official notice.
  2. Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
  3. Ask the pharmacy or supplier about a replacement or refund.

General guidance from Recall Atlas. The official notice from the US Food and Drug Administration has the exact models, batch codes and remedy, and it takes priority.

More Tailstorm Health recalls

  1. 2025-07-09
  2. US
    Drugs & medicalClass II

    Tailstorm Health INC recalls KETAmine Hydrochloride Injection, USP, 50 mg/5mL (10 mg/mL), For IM Use or Slow IV Use, 5 mL Sterile Single-Dose Vial, Rx Only, For Office…

    Lack of Assurance of Sterility: A recent FDA inspection revealed concerns with the sterile manufacturing process.

    FDA · DrugTailstorm Health INCNationwide in the USOfficial notice →
  3. 2024-07-17
  4. US
All 3 Tailstorm Health recalls →

Other drugs & medical recalls in the United States

  1. 2024-11-27
  2. US
    Drugs & medicalClass II

    Safecor Health, LLC recalls Aspirin Chewable tablet 81 mg, 1 tablet in blister card-foils, 100-count unit dose box, www.safecorhealth.com, NDC 48433-129-01

    cGMP Deviations: Observations were made that some blister card-foils were separating from the blister cavity.

    FDA · DrugSafecor Health, LLCUSA nationwide.Official notice →
  3. US
    Drugs & medicalClass II

    Noven Pharmaceuticals Inc recalls Xelstrym (dextroamphetamine) transdermal system, 13.5 mg dextroamphetamine/9 hours, 30 individually sealed transdermal patches, inside…

    Defective Delivery System: The product does not meet predetermined specifications for Coldflow (adhesive).

    FDA · DrugNoven Pharmaceuticals IncUSA nationwide.Official notice →
  4. US
    Drugs & medicalClass II

    Lupin Pharmaceuticals Inc. recalls Ramipril Capsules USP 10 mg, a) 90 count (NDC 68180-591-09), b) 100 count NDC 68180-591-01), and c) 500 count (NDC 68180-591-02)…

    CGMP Deviations: Active pharmaceutical ingredient was sourced from an unapproved vendor

    FDA · DrugLupin Pharmaceuticals Inc.Product was distributed to 30 wholesalers/distributors who may have further…Official notice →
  5. US
    Drugs & medicalClass II

    The Harvard Drug Group LLC dba Major Pharmaceuticals and… recalls Guaifenesin Dextromethorphan Syrup, 100 mg/10mg per 5 mL, Major Pharmaceuticals 8401 Bearing Drive,…

    Failed Impurity/Degradation Specifications

    FDA · DrugThe Harvard Drug Group LLC dba Major Pharmaceuticals and…Nationwide within the United StatesOfficial notice →
  6. US
    Drugs & medicalClass III

    Padagis US LLC recalls Triamcinolone Acetonide Cream USP, 0.025%, 1 LB (454 g) per jar, Rx Only, Manufactured By Padagis, Minneapolis, MN 55427. NDC: 45802-0063-05

    Subpotent and Superpotent Drug. Out of specification assay results recorded as part of Uniformity of Container test during long-term stability testing.

    FDA · DrugPadagis US LLCNationwide in the USAOfficial notice →
  7. US
See all drugs & medical recalls →